Pancreatic cancer is one of the deadliest types of cancer, with fewer than 13% of people diagnosed with it surviving for more ...
A recent modification to the contract would have allowed Vaxart to invoice BARDA for the remaining $230 million or so for ...
US federal health officials and experts say there is no evidence that residual DNA from the COVID-19 vaccines can integrate into human DNA ...
A false claim is circulating online that the European Medicines Agency (EMA) has acknowledged that mRNA vaccines have not ...
A personalized mRNA vaccine for pancreatic cancer has shown early promise in a small phase 1 trial ... [+] of 16 people. A mRNA-based cancer vaccine has shown impressive results in a small trial ...
A new LNP-mRNA vaccine significantly boosts immune response and enhances BCG protection against tuberculosis, offering a ...
There is new hope in the fight against pancreatic cancer after early trials showed that personalized mRNA vaccines can target ...
As global capital reassesses the investment value of innovative Chinese companies, the development of innovative vaccines in ...
A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study ...
The Phase I data aligns with previous preclinical findings, showing over 95% protection in non-human primates, comparable to ...